RxDoctor Payments Data

Jorge Santana Bagur

Infectious Disease · Manati, PRNPI 1063463586

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Viiv Healthcare Company at 38.8% of the total. Reporting peaked in 2019 at $84,702 and has fallen 96.1% since, to $3,313 in 2025. Among infectious disease clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$180,226in general payments, 2019–2025

Across 263 payments — averaging $685.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$70K
  • AbbVie$57K
  • Gilead$48K
  • Merck$2K
  • Modernatx, Inc.$2K
  • GSK$1K
  • plus $263 from 4 others
$328,398in research payments, 2019–2025

Across 143 payments — averaging $2296.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$156K
  • Gilead$142K
  • Merck$29K
  • AbbVie$2K

What the payments were for

  • Consulting fees$59,95033%
  • Speaking & faculty fees$98,99655%
  • Travel & lodging$14,4258%
  • Food & beverage$6,8554%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viiv Healthcare Company67$69,979
AbbVie(2 entities)90$56,654
Gilead81$48,326
Merck2$1,800
Modernatx, Inc.6$1,774
GSK9$1,430
Ferring Pharmaceuticals Inc.1$92
Johnson & Johnson4$90
Shionogi Inc2$50
Astellas Pharma US Inc1$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$180,226 in reported general payments places this provider in the 95th percentile of 127 infectious disease providers in Puerto Rico.

See all infectious disease providers in Puerto Rico

Other infectious disease in Manati

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →